Clinical Trial Update: Safety, Immunogenicity, and Protective Efficacy of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) During Malaria Transmission Season in Healthy African Adult Women of Childbearing Potential in Mali [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety, immunogenicity, and protective efficacy of radiation-attenuated PfSPZ vaccine during malaria transmission season in healthy adul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• PfSPZ Vaccine (Plasmodium falciparum sporozoite vaccine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Malaria | Phase 2 | Status: COMPLETED | Results posted: 2024-03-19